Synergistic Strategies in Systemic Therapy for Advanced Hepatocellular Carcinoma

ABSTRACT Hepatocellular carcinoma (HCC) remains the most prevalent primary liver cancer, characterized by alarmingly high mortality rates and low five‐year survival outcomes. A significant challenge in HCC management lies in its advanced‐stage treatment, with most cases identified at advanced, unres...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Yongxin Yu, Yulang Jiang, Yipeng Yang, Christian Glandorff, Wenzheng Fang, Mingyu Sun
Format:	Artigo
Jezik:	Inglês
Izdano:	Wiley 2026-01-01
Serija:	Global Challenges
Teme:	hepatocellular carcinoma immune checkpoint inhibitor lenvatinib sorafenib systemic treatment tyrosine kinase inhibitor
Online dostop:	https://doi.org/10.1002/gch2.202500247
Oznake:	Označite Brez oznak, prvi označite!